BEGIN:VCALENDAR VERSION:2.0 PRODID:unctad.org BEGIN:VEVENT UID:6a591c75e2ab5 DTSTART:20230627T060000Z SEQUENCE:0 TRANSP:OPAQUE DTEND:20230627T140000Z LOCATION:Addis Ababa\, Ethiopia SUMMARY:Global event on enhancing the sustainability of investment for vacc ine manufacturing in Africa CLASS:PUBLIC DESCRIPTION:Following the COVID-19 pandemic\, African countries and develop ment partners have prioritised investment into vaccines manufacturing capa city with a view to overcome health inequities. The Partnership for Africa n Vaccine Manufacturing (PAVM)\, under Africa CDC was launched in 2021 and its Framework for Action in 2022. PAVM targets a call by the African Unio n heads of State and Government for the local production of 60% of the vac cine the region requires by 2040.\n\nObjectives: \n\nAround 30 investment initiatives for vaccines manufacturing in Africa have been announced since COVID-19. The key question that the event is intended to address is how t o develop sustainable investment in vaccine manufacturing that will mitiga te the risks and ensure financial sustainability. For this purpose\, the e vent will:\n\n\nOutline the progress made on investment in vaccine manufac turing in Africa\, while creating transparency on the current financing ga p\, as well as the pain points experienced by investment projects to date. \nProvide a platform to facilitate business to business linkages and match making between investors\, manufacturers\, and financial providers.\nIdent ify potential solutions to enhance sustainability of investment.\n\n\nThe event will also facilitate initial exchange on the opportunities for inves tment in biopharmaceuticals that are critical to making vaccines investmen t sustainable.\n<\;p>\;Following the COVID-19 pandemic\, African count ries and development partners have prioritised investment into vaccines ma nufacturing capacity with a view to overcome health inequities. The Partne rship for African Vaccine Manufacturing (PAVM)\, under Africa CDC was laun ched in 2021 and its Framework for Action in 2022. PAVM targets a call by the African Union heads of State and Government for the local production o f 60% of the vaccine the region requires by 2040.<\;/p>\;\n\n<\;p> \;<\;strong>\;Objectives: <\;/strong>\;<\;/p>\;\n\n<\;p>\; Around 30 investment initiatives for vaccines manufacturing in Africa have been announced since COVID-19. The key question that the event is intende d to address is how to develop sustainable investment in vaccine manufactu ring that will mitigate the risks and ensure financial sustainability. For this purpose\, the event will:<\;/p>\;\n\n<\;ol>\;\n<\;li>\;O utline the progress made on investment in vaccine manufacturing in Africa\ , while creating transparency on the current financing gap\, as well as th e pain points experienced by investment projects to date.<\;/li>\;\n&l t\;li>\;Provide a platform to facilitate business to business linkages a nd matchmaking between investors\, manufacturers\, and financial providers .<\;/li>\;\n<\;li>\;Identify potential solutions to enhance sustai nability of investment.<\;/li>\;\n<\;/ol>\;\n\n<\;p>\;The even t will also facilitate initial exchange on the opportunities for investmen t in biopharmaceuticals that are critical to making vaccines investment su stainable.<\;/p>\;\n\n\nView meeting on unctad.org\nhttps://unctad.org /meeting/global-event-enhancing-sustainability-investment-vaccine-manufact uring-africa DTSTAMP:20260716T180125Z END:VEVENT BEGIN:VEVENT UID:6a591c75e2b17 DTSTART:20230628T060000Z SEQUENCE:0 TRANSP:OPAQUE DTEND:20230628T140000Z LOCATION:Addis Ababa\, Ethiopia SUMMARY:Global event on enhancing the sustainability of investment for vacc ine manufacturing in Africa CLASS:PUBLIC DESCRIPTION:Following the COVID-19 pandemic\, African countries and develop ment partners have prioritised investment into vaccines manufacturing capa city with a view to overcome health inequities. The Partnership for Africa n Vaccine Manufacturing (PAVM)\, under Africa CDC was launched in 2021 and its Framework for Action in 2022. PAVM targets a call by the African Unio n heads of State and Government for the local production of 60% of the vac cine the region requires by 2040.\n\nObjectives: \n\nAround 30 investment initiatives for vaccines manufacturing in Africa have been announced since COVID-19. The key question that the event is intended to address is how t o develop sustainable investment in vaccine manufacturing that will mitiga te the risks and ensure financial sustainability. For this purpose\, the e vent will:\n\n\nOutline the progress made on investment in vaccine manufac turing in Africa\, while creating transparency on the current financing ga p\, as well as the pain points experienced by investment projects to date. \nProvide a platform to facilitate business to business linkages and match making between investors\, manufacturers\, and financial providers.\nIdent ify potential solutions to enhance sustainability of investment.\n\n\nThe event will also facilitate initial exchange on the opportunities for inves tment in biopharmaceuticals that are critical to making vaccines investmen t sustainable.\n<\;p>\;Following the COVID-19 pandemic\, African count ries and development partners have prioritised investment into vaccines ma nufacturing capacity with a view to overcome health inequities. The Partne rship for African Vaccine Manufacturing (PAVM)\, under Africa CDC was laun ched in 2021 and its Framework for Action in 2022. PAVM targets a call by the African Union heads of State and Government for the local production o f 60% of the vaccine the region requires by 2040.<\;/p>\;\n\n<\;p> \;<\;strong>\;Objectives: <\;/strong>\;<\;/p>\;\n\n<\;p>\; Around 30 investment initiatives for vaccines manufacturing in Africa have been announced since COVID-19. The key question that the event is intende d to address is how to develop sustainable investment in vaccine manufactu ring that will mitigate the risks and ensure financial sustainability. For this purpose\, the event will:<\;/p>\;\n\n<\;ol>\;\n<\;li>\;O utline the progress made on investment in vaccine manufacturing in Africa\ , while creating transparency on the current financing gap\, as well as th e pain points experienced by investment projects to date.<\;/li>\;\n&l t\;li>\;Provide a platform to facilitate business to business linkages a nd matchmaking between investors\, manufacturers\, and financial providers .<\;/li>\;\n<\;li>\;Identify potential solutions to enhance sustai nability of investment.<\;/li>\;\n<\;/ol>\;\n\n<\;p>\;The even t will also facilitate initial exchange on the opportunities for investmen t in biopharmaceuticals that are critical to making vaccines investment su stainable.<\;/p>\;\n\n\nView meeting on unctad.org\nhttps://unctad.org /meeting/global-event-enhancing-sustainability-investment-vaccine-manufact uring-africa DTSTAMP:20260716T180125Z END:VEVENT BEGIN:VEVENT UID:6a591c75e2b24 DTSTART:20230629T060000Z SEQUENCE:0 TRANSP:OPAQUE DTEND:20230629T140000Z LOCATION:Addis Ababa\, Ethiopia SUMMARY:Global event on enhancing the sustainability of investment for vacc ine manufacturing in Africa CLASS:PUBLIC DESCRIPTION:Following the COVID-19 pandemic\, African countries and develop ment partners have prioritised investment into vaccines manufacturing capa city with a view to overcome health inequities. The Partnership for Africa n Vaccine Manufacturing (PAVM)\, under Africa CDC was launched in 2021 and its Framework for Action in 2022. PAVM targets a call by the African Unio n heads of State and Government for the local production of 60% of the vac cine the region requires by 2040.\n\nObjectives: \n\nAround 30 investment initiatives for vaccines manufacturing in Africa have been announced since COVID-19. The key question that the event is intended to address is how t o develop sustainable investment in vaccine manufacturing that will mitiga te the risks and ensure financial sustainability. For this purpose\, the e vent will:\n\n\nOutline the progress made on investment in vaccine manufac turing in Africa\, while creating transparency on the current financing ga p\, as well as the pain points experienced by investment projects to date. \nProvide a platform to facilitate business to business linkages and match making between investors\, manufacturers\, and financial providers.\nIdent ify potential solutions to enhance sustainability of investment.\n\n\nThe event will also facilitate initial exchange on the opportunities for inves tment in biopharmaceuticals that are critical to making vaccines investmen t sustainable.\n<\;p>\;Following the COVID-19 pandemic\, African count ries and development partners have prioritised investment into vaccines ma nufacturing capacity with a view to overcome health inequities. The Partne rship for African Vaccine Manufacturing (PAVM)\, under Africa CDC was laun ched in 2021 and its Framework for Action in 2022. PAVM targets a call by the African Union heads of State and Government for the local production o f 60% of the vaccine the region requires by 2040.<\;/p>\;\n\n<\;p> \;<\;strong>\;Objectives: <\;/strong>\;<\;/p>\;\n\n<\;p>\; Around 30 investment initiatives for vaccines manufacturing in Africa have been announced since COVID-19. The key question that the event is intende d to address is how to develop sustainable investment in vaccine manufactu ring that will mitigate the risks and ensure financial sustainability. For this purpose\, the event will:<\;/p>\;\n\n<\;ol>\;\n<\;li>\;O utline the progress made on investment in vaccine manufacturing in Africa\ , while creating transparency on the current financing gap\, as well as th e pain points experienced by investment projects to date.<\;/li>\;\n&l t\;li>\;Provide a platform to facilitate business to business linkages a nd matchmaking between investors\, manufacturers\, and financial providers .<\;/li>\;\n<\;li>\;Identify potential solutions to enhance sustai nability of investment.<\;/li>\;\n<\;/ol>\;\n\n<\;p>\;The even t will also facilitate initial exchange on the opportunities for investmen t in biopharmaceuticals that are critical to making vaccines investment su stainable.<\;/p>\;\n\n\nView meeting on unctad.org\nhttps://unctad.org /meeting/global-event-enhancing-sustainability-investment-vaccine-manufact uring-africa DTSTAMP:20260716T180125Z END:VEVENT END:VCALENDAR